Literature DB >> 15340389

Paul Ehrlich: magister mundi.

Jürgen Drews.   

Abstract

Paul Ehrlich, a founding father in fields across a wide range of medical sciences, was born 150 years ago. To mark this anniversary, this article gives an overview of his life, highlighting his major scientific contributions and paying tribute to Paul Ehrlich the man.

Entities:  

Mesh：

Year:  2004        PMID： 15340389     DOI： 10.1038/nrd1498

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


  16 in total

Review 1.  Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis.

Authors:  Jamie Campbell; David Lowe; Matthew A Sleeman
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 2.  The birth pangs of monoclonal antibody therapeutics: the failure and legacy of Centoxin.

Authors:  Lara Marks
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

Review 3.  The two faces of IL-6 in the tumor microenvironment.

Authors:  Daniel T Fisher; Michelle M Appenheimer; Sharon S Evans
Journal:  Semin Immunol       Date:  2014-03-03       Impact factor: 11.130

Review 4.  A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.

Authors:  Gregory S Bisacchi; Michael R Hale
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

5.  Moving molecularly directed therapies to the first-line in ALK-positive lung cancer: crizotinib is just the beginning.

Authors:  Samuel J Klempner; Alexander Raufi; Sai-Hong Ignatius Ou
Journal:  Transl Lung Cancer Res       Date:  2015-10

6.  An Insight into Photophysical Investigation of (E)-2-Fluoro-N'-(1-(4-Nitrophenyl)Ethylidene)Benzohydrazide through Solvatochromism Approaches and Computational Studies.

Authors:  Ditto Abraham Thadathil; Shanu Varghese; K B Akshaya; Renjith Thomas; Anitha Varghese
Journal:  J Fluoresc       Date:  2019-07-15       Impact factor: 2.217

Review 7.  The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize.

Authors:  Fèlix Bosch; Laia Rosich
Journal:  Pharmacology       Date:  2008-08-05       Impact factor: 2.547

Review 8.  The evolving role of chemical synthesis in antibacterial drug discovery.

Authors:  Peter M Wright; Ian B Seiple; Andrew G Myers
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-02       Impact factor: 15.336

Review 9.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

Review 10.  Complement in immune and inflammatory disorders: therapeutic interventions.

Authors:  Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2013-04-15       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.